Role of FACT Proteins in Regulating HIV Transcription and Latency
FACT 蛋白在调节 HIV 转录和潜伏期中的作用
基本信息
- 批准号:9139906
- 负责人:
- 金额:$ 29.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-15 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcquired Immunodeficiency SyndromeAffectAnti-Retroviral AgentsBackBindingCD4 Positive T LymphocytesCell modelCellsChromatinComplexDNA Polymerase IIDataDepositionDiseaseFoundationsGenesGeneticGenetic TranscriptionGoalsHIVHIV-1HealthHighly Active Antiretroviral TherapyHistonesIn VitroInfectionIntegration Host FactorsInvestigationKnowledgeLeadLightMapsMeasuresMediatingMolecularMolecular ChaperonesNucleosomesPatientsPlayPositive Transcriptional Elongation Factor BProcessProteinsProvirusesRNA InterferenceRecruitment ActivityRegimenResidual stateRestRoleSeriesSmall Interfering RNAStructureT-LymphocyteTestingViralViral Load resultViremiaVirusVirus Latencyantiretroviral therapybasedimerfollow-upgenome-wideimprovedin vivointerdisciplinary approachinterestmemory CD4 T lymphocytenovelpreventpromoterpurgereactivation from latencyresearch study
项目摘要
DESCRIPTION (provided by applicant): Although HAART is successful to block active replication of HIV-1 in AIDS patients, it does not eradicate viruses. Presence of latent HIV-1 reservoirs remains a major obstacle to the cure. Recently, it was uncovered that the size of latent HIV-1 reservoirs is much larger than previously estimated. Thus, identification of novel host genes that can be targeted for reverting HIV-1 latency is urgent. Our recent studies of host factors modulating HIV-1 replication identified that FACT (facilitates chromatin transcription) proteins, SUPT16H and SSRP1, restrict HIV-1 replication. Our further studies demonstrated that FACT proteins interfere with TAT-LTR transcriptional activities, and depletion of FACT proteins enhances HIV-1 transcription and facilitates reactivation of latent HIV-1. In this proposal, we wil explore molecular mechanisms how FACT proteins negatively regulate HIV-1 replication. Aim 1: Our genetic data showed that depletion of FACT proteins significantly enhance HIV-1 transcription. It was a surprising result considering that FACT proteins generally facilitate transcription. It is critical to study FACT's function under circumstance of HIV-1 infection, which
will provide new knowledge about FACT functions that might be unique for HIV-1. We postulate two possible mechanisms that might lead to FACT suppressive activities: (i). Presence of FACT proteins might affect P- TEFb activity in HIV-1 transcriptional elongation; (ii). FACT proteins might process altered nucleosome exchange activity for HIV-1 transcription. These hypotheses will be thoroughly tested by a series of experiments using multidisciplinary approaches. Aim 2: Our preliminary results indicated that SUPT16H might directly bind with HIV-1 TAT and recruit to LTR promoter. However, a lot of information still lacks for further characterization of these interactions. Thus, we will study the molecular details of FACT interactions with HIV-1 TAT-LTR as well as other key host transcriptional factors (PAF1 and P-TEFb). We will (i) map which domain(s) of SUPT16H mediate its direct interaction with TAT; (ii) determine whether LTR recruitment of SUPT16H depends on TAT or PAF1; (iii) evaluate the impact of FACT proteins on P-TEFb and TAT-LTR interactions. Aim 3: If indeed FACT proteins impose an inhibitory effect on HIV-1 transcription, through which they might play a role in regulating HIV-1 latency. Our earlier results using HIV-1 latently infected J-LAT cells confirmed that depletion of FACT proteins by RNAi spontaneously reverts HIV-1 latency. In this aim, we will further evaluate the effects of FACT proteins on HIV-1 latency in a primary CD4+ T cell model: (i) Role of FACT proteins in suppressing HIV-1 transcription for latency establishment will be determined; (ii) Effects of FACT protein depletion on HIV-1 reactivation from latency will be measured. (iii) Coordination of FACT proteins with other HIV-1 transcriptional suppressors, histone deacetylases (HDACs), will be investigated. Above all, we expect that our in-depth functional studies of FACT proteins will shed light in understanding their roles in HIV-1 replication and provide sufficient scientific foundation to target them for HIV-1 anti-latency therapy.
描述(由申请人提供):尽管HAART成功地阻断了艾滋病患者体内HIV-1的活跃复制,但它不能根除病毒。潜伏的HIV-1储库的存在仍然是治愈的主要障碍。最近,人们发现潜伏的HIV-1病毒库的规模比以前估计的要大得多。因此,鉴定新的宿主基因,可以有针对性地逆转HIV-1潜伏期是迫切的。我们最近对调节HIV-1复制的宿主因子的研究发现,FACT(促进染色质转录)蛋白SUPT 16 H和SSRP 1限制HIV-1复制。我们的进一步研究表明,FACT蛋白干扰TAT-LTR转录活性,FACT蛋白的缺失增强HIV-1转录并促进潜伏HIV-1的再激活。在本研究中,我们将探讨FACT蛋白负调控HIV-1复制的分子机制。目的1:我们的遗传数据表明,FACT蛋白的缺失显着增强HIV-1的转录。考虑到FACT蛋白通常促进转录,这是一个令人惊讶的结果。研究FACT在HIV-1感染情况下的功能至关重要,
将提供关于FACT功能的新知识,这些功能可能是HIV-1所独有的。我们假设可能导致FACT抑制活性的两种可能机制:(i)。FACT蛋白的存在可能影响P-TEFb在HIV-1转录延伸中的活性;(ii). FACT蛋白可能改变HIV-1转录的核小体交换活性。这些假设将通过使用多学科方法的一系列实验进行彻底测试。目的2:我们的初步研究结果表明SUPT 16 H可能直接与HIV-1达特结合并募集到LTR启动子。然而,许多信息仍然缺乏进一步表征这些相互作用。因此,我们将研究FACT与HIV-1 TAT-LTR以及其他关键宿主转录因子(PAF 1和P-TEFb)相互作用的分子细节。我们将(i)绘制SUPT 16 H的哪个或哪些结构域介导其与达特的直接相互作用;(ii)确定SUPT 16 H的LTR募集是否依赖于达特或PAF 1;(iii)评价FACT蛋白对P-TEFb和TAT-LTR相互作用的影响。目的3:如果FACT蛋白确实对HIV-1转录产生抑制作用,那么它们可能在调节HIV-1潜伏期中发挥作用。我们使用HIV-1潜伏感染的J-LAT细胞的早期结果证实,通过RNAi消耗FACT蛋白自发地逆转HIV-1潜伏期。为此,我们将在原代CD 4 + T细胞模型中进一步评价FACT蛋白对HIV-1潜伏期的影响:(i)将确定FACT蛋白在抑制HIV-1转录以建立潜伏期中的作用;(ii)将测量FACT蛋白耗竭对HIV-1从潜伏期再激活的影响。(iii)将研究FACT蛋白与其他HIV-1转录抑制因子组蛋白脱乙酰酶(HDAC)的协调作用。最重要的是,我们希望我们对FACT蛋白的深入功能研究将有助于了解它们在HIV-1复制中的作用,并为靶向它们进行HIV-1抗潜伏期治疗提供足够的科学基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jian Zhu其他文献
Jian Zhu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jian Zhu', 18)}}的其他基金
Role of RNA Methylation in Regulating HIV Proviral Expression
RNA 甲基化在调节 HIV 原病毒表达中的作用
- 批准号:
10426418 - 财政年份:2021
- 资助金额:
$ 29.56万 - 项目类别:
Role of FACT Proteins in Regulating HIV Transcription and Latency
FACT 蛋白在调节 HIV 转录和潜伏期中的作用
- 批准号:
9335501 - 财政年份:2015
- 资助金额:
$ 29.56万 - 项目类别:
Investigation of Latency Promoting Genes (LPGs) in HIV Oral Reservoir Cells
HIV 口腔储存细胞潜伏期促进基因 (LPG) 的研究
- 批准号:
9283243 - 财政年份:2015
- 资助金额:
$ 29.56万 - 项目类别:
Role of FACT Proteins in Regulating HIV Transcription and Latency
FACT 蛋白在调节 HIV 转录和潜伏期中的作用
- 批准号:
9716746 - 财政年份:2015
- 资助金额:
$ 29.56万 - 项目类别:
Role of FACT Proteins in Regulating HIV Transcription and Latency
FACT 蛋白在调节 HIV 转录和潜伏期中的作用
- 批准号:
8920866 - 财政年份:2015
- 资助金额:
$ 29.56万 - 项目类别:
Cooperation of BRD4 and TAT Associated Proteins in HIV Transcription and Latency
BRD4 和 TAT 相关蛋白在 HIV 转录和潜伏期中的合作
- 批准号:
8841576 - 财政年份:2014
- 资助金额:
$ 29.56万 - 项目类别:
Cooperation of BRD4 and TAT Associated Proteins in HIV Transcription and Latency
BRD4 和 TAT 相关蛋白在 HIV 转录和潜伏期中的合作
- 批准号:
9319617 - 财政年份:2014
- 资助金额:
$ 29.56万 - 项目类别:
Identification of HIV-1 Restriction Factors through Functional Genomic Screens
通过功能基因组筛选鉴定 HIV-1 限制因素
- 批准号:
8432608 - 财政年份:2012
- 资助金额:
$ 29.56万 - 项目类别:
Identification of HIV-1 Restriction Factors through Functional Genomic Screens
通过功能基因组筛选鉴定 HIV-1 限制因素
- 批准号:
8255929 - 财政年份:2012
- 资助金额:
$ 29.56万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 29.56万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 29.56万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 29.56万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 29.56万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 29.56万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 29.56万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 29.56万 - 项目类别:














{{item.name}}会员




